Project Grant K01AI190052
Award Date
7/1/25
Completion Date
6/30/30
Dollars Obligated
$129K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $395,496 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Regents of the University of California, San Francisco (UCSF) effective August 23, 2024. The funding will support a research project titled "Metagenomic Surveillance of Pathogen and Antimicrobial Resistance Gene Transmission in Hospitalized Neonates." The project aims to leverage metagenomic next-generation sequencing...
This federal Project Grant award of $169,811, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research conducted by the University of North Carolina at Chapel Hill (UNC-CH) to develop and apply innovative statistical methods for estimating the overall and spillover effects of infectious disease prevention interventions. The primary goal is to acquire training in infectious disease...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $175,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to California State University, Fresno. The grant, titled "Surveillance of Drug-Resistant Bacteria in Resource-Limited Settings: A Focus on Cost-Effective Long-Read Sequencing of Eyedrop-Associated P. Aeruginosa and Locally Sourced Metagenomic Samples," aims to develop a decentralized antimicrobial resistance...
This $171,089 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research into the genetic and phenotypic adaptations of vancomycin-resistant Enterococcus faecium (VREFM) during recurrent bloodstream infections. The key objectives are to: 1) conduct comparative genomic analyses of VREFM isolates from patients with recurrent infections to identify genetic signatures associated...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify genomic determinants of antibiotic treatment failure in Staphylococcus aureus bacteremia. The $189,558 award to Duke University aims to use patient data, bacterial isolates, and genomic/laboratory studies to determine the link between bacterial biology and clinical outcomes. The research will focus...
This $453,900 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding research to develop a genome editing platform using broadly functioning phage recombinases, which can be used to genetically manipulate a wide range of bacterial species, including clinically relevant pathogens. The goal is to enable direct investigation of the genetic elements driving bacterial...
This Project Grant award, valued at $792,687.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural features of sialoglycans necessary for influenza A virus (IAV) infection and adaptation across various host species. The key activities under this award include: 1) using CRISPR/Cas9 techniques to truncate different types of sialoglycans in human lung...
This federal Project Grant award, valued at $243,361.00 and running from August 15, 2024 to July 31, 2026, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is funding a project by Rush University Medical Center in Chicago, Illinois to establish workflows for rapid and inexpensive whole genome sequencing (WGS) of Neisseria gonorrhoeae (NG) directly from urine, throat, and rectal...
The federal Project Grant award of $700,288 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to identify genetic factors associated with the development of sexual stages (gametocytes) in the malaria parasite Plasmodium falciparum. The project combines expertise in gametocyte biology, advanced computational genomics, and phenotype comparisons with clinical...
This $134,800 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research by Dr. Shakti Singh at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The project aims to: Study the role of Hyr1/Iff-like (CAU-HIL) proteins in the virulence of the multidrug-resistant pathogen Candida auris, which causes life-threatening bloodstream infections....